Digital Therapeutic Market Access


Theranica is a prescription digital therapeutics company the manufactures and markets Nerivio™, a wireless remote electrical neuromodulation device for the acute treatment of migraine


DTxCC developed the Nerivio market access strategy

  • Live Payer advisory board meeting

  • Commercial Payer market access strategy development

  • VA market strategy and implementation plan

  • Real world evidence data monetization strategic options


2 views0 comments

Recent Posts

See All
  • LinkedIn
  • Twitter

DTxCC
Digital Therapeutics Commercialization Consultants

Homestead Drive

West Chester, PA 19382 

Rick@dtxcc.com  |  Tel: 610-533-2118

©2021 by Digital Therapeutics Commercialization Consultants, LLC.